OTCMKTS:BOIRF Boiron (BOIRF) Stock Price, News & Analysis → War Over Taiwan? Protect Your Wealth NOW (From Behind the Markets) (Ad) Free BOIRF Stock Alerts $36.81 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share Today's Range$36.81▼$36.8150-Day Range$35.25▼$38.4752-Week Range$35.25▼$53.50VolumeN/AAverage Volume167 shsMarket CapitalizationN/AP/E Ratio9.34Dividend Yield3.26%Price TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartHeadlinesShort Interest Get Boiron alerts: Email Address Ad Behind the MarketsWar Over Taiwan? Protect Your Wealth NOWWith tensions rapidly escalating, Taiwan could provide the spark at any moment. Don't let your financial future get caught in the crossfire unprepared.Access my report now >>> About Boiron Stock (OTCMKTS:BOIRF)Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain. In addition, it offers Dermoplasmine, a plant based multi-use balm that repairs and protects irritated and damaged skin; COVID self-tests and rapid antigenic tests; LABIAMEO, that used to treat outbreaks of localized cold sores; and CONVAMEO to treat physical and mental asthenia. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.Read More BOIRF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BOIRF Stock News HeadlinesMarch 21, 2024 | msn.comLip Filler Aftercare Tips to Protect Your New Pout, According to a DermatologistMarch 6, 2024 | msn.comHow to Get Rid of a Hickey as Fast as PossibleApril 26, 2024 | Behind the Markets (Ad)War Over Taiwan? Protect Your Wealth NOWWith tensions rapidly escalating, Taiwan could provide the spark at any moment. Don't let your financial future get caught in the crossfire unprepared.February 25, 2024 | finanznachrichten.dePuuilo Oyj: Business Review Q3 2023: The journey continues at a good paceFebruary 24, 2024 | theguardian.comI was a hedge fund billionaire’s PA. It nearly killed meFebruary 10, 2024 | investopedia.comFree on Board (FOB) Explained: Who's Liable for What in Shipping?February 5, 2024 | tmcnet.comDexory to Re-define North American Logistics and Warehousing Technology MarketFebruary 3, 2024 | news.yahoo.com21-year-old woman hurt in overnight Danville shootingApril 26, 2024 | Behind the Markets (Ad)War Over Taiwan? Protect Your Wealth NOWWith tensions rapidly escalating, Taiwan could provide the spark at any moment. Don't let your financial future get caught in the crossfire unprepared.February 2, 2024 | news.yahoo.comCorpus Christi is moving forward with its desalination project. Here's what's next.February 2, 2024 | news.yahoo.comJetBlue passengers help restrain unruly flyer on flight to New YorkFebruary 2, 2024 | news.yahoo.comForestry work prompts site restrictions at Island Lake Fishing AccessFebruary 2, 2024 | msn.comAmtrak pledges to double riders by 2040 with expansion plansFebruary 2, 2024 | techcrunch.comThree San Francisco supervisors receive threats following YC President Garry Tan’s tweetFebruary 2, 2024 | techcrunch.comMedia startup The Messenger disintegrates, leaving staff nothingFebruary 2, 2024 | news.yahoo.comKim Jong Un calls for boosting ‘war preparations’ at naval shipyardFebruary 2, 2024 | news.yahoo.comTaco Bell thanks fire station that helped food delivery driver involved in wreckFebruary 1, 2024 | msn.comClemson football lands quarterback recruit late in 2024 cycleFebruary 1, 2024 | yahoo.comAdidas announces plan to sell leftover Yeezy sneakersFebruary 1, 2024 | news.yahoo.comValentine's and Super Bowl Cocktails with The Cocktail GuruFebruary 1, 2024 | news.yahoo.comWhat’s it like to live Black history? Ruby Bridges has some thoughts.February 1, 2024 | msn.comWATCH: Our Heroes Rock Presents ‘Bridges’February 1, 2024 | ca.style.yahoo.comPolygon Labs lays off 60 employees, about 19% of its staff, CEO saysFebruary 1, 2024 | yahoo.com$1 million scratch-off winner sold in Montgomery CountyJanuary 31, 2024 | yahoo.comIs Your Plantar Fasciitis Pain So Bad You Can’t Walk? Podiatrists Reveal Why You Likely *Don’t* Need SurgeryJanuary 12, 2024 | cnet.com7 of the Best Board Games to Give in 2023January 11, 2024 | msn.com11 items Amazon can deliver to your doorstep to help beat cold and flu seasonSee More Headlines Receive BOIRF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Boiron and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:BOIRF CUSIPN/A CIKN/A Webwww.boiron.com Phone33 4 78 45 61 00FaxN/AEmployees2,813Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio9.34 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMs. Valérie Lorentz-Poinsot (Age 55)GM & Executive Director Comp: $1.05MMr. Jean-Christophe Bayssat (Age 61)Deputy GM, Chief Pharmacist & Director of Pharmaceutical Development Comp: $437.54kMr. Eric LambertSecretary General and Chief Financial & Administrative OfficerMr. Patrice VarrautDirector of OperationsMs. Juliette BaudryHuman Resources DirectorFabrice ReyGroup TreasurerMore ExecutivesKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors BOIRF Stock Analysis - Frequently Asked Questions Should I buy or sell Boiron stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Boiron in the last year. There are currently 1 sell rating for the stock. The consensus among Wall Street equities research analysts is that investors should "sell" BOIRF shares. View BOIRF analyst ratings or view top-rated stocks. How have BOIRF shares performed in 2024? Boiron's stock was trading at $42.54 at the beginning of the year. Since then, BOIRF shares have decreased by 13.5% and is now trading at $36.81. View the best growth stocks for 2024 here. Is Boiron a good dividend stock? Boiron (OTCMKTS:BOIRF) pays an annual dividend of $1.20 per share and currently has a dividend yield of 2.01%. The dividend payout ratio is 30.44%. This payout ratio is at a healthy, sustainable level, below 75%. How do I buy shares of Boiron? Shares of BOIRF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BOIRF) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupTrump is sounding the alarmPreserve Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Boiron SA Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.